AI-generated analysis. Always verify with the original filing.
On March 3, 2026, the NYSE notified Vicarious Surgical Inc. that it suspended trading in the Company's Common Stock due to falling below the $15,000,000 average global market capitalization continued listing standard and commenced delisting proceedings. The Company expects quotation on the OTCID market tier under 'RBOT' starting March 4, 2026.
Event Type
Disclosure
Mandatory
Variant
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On March 3, 2026, the New York Stock Exchange (the “NYSE”)
Regulation FD Disclosure. On March 4, 2026, the Company issued a press release announcing the matters disclosed in Item 3.01 above. The press release is furnish
. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by Vicarious Surgical Inc., dated March 4, 2026 104 Cover Pa